中国远大集团医药健康下属由华东医药 (深交所：963) 、远大医药集团 (港交所：512)、雷允上药业集团、远大生物科技集团组成，提供化学制剂、中药制剂、以血液制品及疫苗为基础的生物制剂等三大类近千品种的成药制剂品种；生产多种大宗原料药和甾体激素类、肾上腺素类等多种特色原料药、精细化工中间体和保健品等多个类别的医药相关产品；已形成各专业领域的营销体系，多项产品通过欧洲COS认证和美国FDA认证。
中国远大集团一直将医药新产品研发作为战略重点，持续投入专项资金，通过构建自主研发平台，产学研相结合和国际合作等多种方式，不断成功开发出新产品投放市场；已经形成了集产品研发、生产、销售于一体，中西药并举，国际和国内市场共同发展的医药健康产业模式。
Company Details
- Employees
- 27
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Yunna.
- Competitors
- Nantong Changhai Food Additive Co., Ltd., Grand Pharmaceutical Group Limited, Nugene Biopharm Science, 中国远大集团有限责任公司, Yunna, Hangzhou Minsheng Pharmaceutical Group Co., Ltd., Gracell Biotechnologies, China Grand Enterprises, Inc., Grand Pharmaceutical Group Limited, Egyptian United Group.
China Grand Pharma Questions
China Grand Pharma's website is http://en.chinagrandinc.com/index.html
China Grand Pharma's LinkedIn profile is https://www.linkedin.com/company/chinagrandpharm
China Grand Pharma has
27 employees.
View email and phone details for 27
employees at China Grand Pharma.
China Grand Pharma's industry is
Pharmaceutical Manufacturing
China Grand Pharma's top competitors are
Nantong Changhai Food Additive Co., Ltd.,
Grand Pharmaceutical Group Limited,
Nugene Biopharm Science,
中国远大集团有限责任公司,
Yunna,
Hangzhou Minsheng Pharmaceutical Group Co., Ltd.,
Gracell Biotechnologies,
China Grand Enterprises, Inc.,
Grand Pharmaceutical Group Limited,
Egyptian United Group.
China Grand Pharma's categories are Pharmaceutical Manufacturing
